Fludrocortisone Is Associated With a Higher Risk of All‐Cause Hospitalizations Compared With Midodrine in Patients With Orthostatic Hypotension

BACKGROUND: Orthostatic hypotension causes ≈80 000 hospitalizations per year in the United States. Treatments for orthostatic hypotension include fludrocortisone, a mineralocorticoid analog that promotes sodium reabsorption; and midodrine, an α‐1 adrenergic agonist that is a direct vasoconstrictor....

Descripción completa

Detalles Bibliográficos
Autores principales: Grijalva, Carlos G., Biaggioni, Italo, Griffin, Marie R., Shibao, Cyndya A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721876/
https://www.ncbi.nlm.nih.gov/pubmed/29025750
http://dx.doi.org/10.1161/JAHA.117.006848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721876/
https://www.ncbi.nlm.nih.gov/pubmed/29025750
http://dx.doi.org/10.1161/JAHA.117.006848

Ejemplares similares